Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis

Critical phases (stages) of preclinical studies are those procedures or types of research activities whose accurate and correct implementation is a prerequisite for obtaining valid and reliable results. Russian and foreign standards require determination of the critical phases of each individual stu...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Khodko, M. N. Makarova, V. G. Makarov, S. S. Salynov, N. V. Rodionova
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2021-10-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
Online Access:https://www.vedomostincesmp.ru/jour/article/view/375
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849249589105786880
author S. V. Khodko
M. N. Makarova
V. G. Makarov
S. S. Salynov
N. V. Rodionova
author_facet S. V. Khodko
M. N. Makarova
V. G. Makarov
S. S. Salynov
N. V. Rodionova
author_sort S. V. Khodko
collection DOAJ
description Critical phases (stages) of preclinical studies are those procedures or types of research activities whose accurate and correct implementation is a prerequisite for obtaining valid and reliable results. Russian and foreign standards require determination of the critical phases of each individual study by quality assurance staff based on checking the study protocol (plan).The aim of the study was to identify critical phases typical for most preclinical studies, and assess the potential risks during inspections.Materials and methods: the study was carried out by analysing the types and consequences of nonconformities. Numerical parameters of risks were analysed for each critical phase of the preclinical study identified by quality officers of the Joint Stock Company “Scientific and Production Association ‘HOME OF PHARMACY’”.Results: it was discovered that incorrect implementation of a procedure constituted a potential nonconformity at all the identified critical phases, and a potential consequence was acquisition of low-quality data. A combination of incorrectly implemented procedures at two or more critical phases could pose an unacceptable risk and lead to complete loss of data or failure to process data, and, as a result, the need to repeat the study.Conclusions: the highest risk was identified for such critical phases as preparation and administration of final doses of test samples, performance of physiological tests, collection of biological material samples, and handling of biological material samples by other relevant departments. Summarising the data obtained on the risks of all the critical phases, it can be concluded that risk action should take the form of regular inspections by the quality assurance staff and the study director. By adjusting the frequency of inspections, the risk of each critical phase can be made insignificant.
format Article
id doaj-art-030d9d70b118477bb64e66caf5b3b9a7
institution Kabale University
issn 3034-3062
3034-3453
language Russian
publishDate 2021-10-01
publisher Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
record_format Article
series Регуляторные исследования и экспертиза лекарственных средств
spelling doaj-art-030d9d70b118477bb64e66caf5b3b9a72025-08-20T03:57:31ZrusFederal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)Регуляторные исследования и экспертиза лекарственных средств3034-30623034-34532021-10-0111319320110.30895/1991-2919-2021-11-193-201277Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk AnalysisS. V. Khodko0M. N. Makarova1V. G. Makarov2S. S. Salynov3N. V. Rodionova4Joint Stock Company “Scientific and Production Association HOME OF PHARMACY”Joint Stock Company “Scientific and Production Association HOME OF PHARMACY”Joint Stock Company “Scientific and Production Association HOME OF PHARMACY”Joint Stock Company “Scientific and Production Association HOME OF PHARMACY”Joint Stock Company “Scientific and Production Association HOME OF PHARMACY”Critical phases (stages) of preclinical studies are those procedures or types of research activities whose accurate and correct implementation is a prerequisite for obtaining valid and reliable results. Russian and foreign standards require determination of the critical phases of each individual study by quality assurance staff based on checking the study protocol (plan).The aim of the study was to identify critical phases typical for most preclinical studies, and assess the potential risks during inspections.Materials and methods: the study was carried out by analysing the types and consequences of nonconformities. Numerical parameters of risks were analysed for each critical phase of the preclinical study identified by quality officers of the Joint Stock Company “Scientific and Production Association ‘HOME OF PHARMACY’”.Results: it was discovered that incorrect implementation of a procedure constituted a potential nonconformity at all the identified critical phases, and a potential consequence was acquisition of low-quality data. A combination of incorrectly implemented procedures at two or more critical phases could pose an unacceptable risk and lead to complete loss of data or failure to process data, and, as a result, the need to repeat the study.Conclusions: the highest risk was identified for such critical phases as preparation and administration of final doses of test samples, performance of physiological tests, collection of biological material samples, and handling of biological material samples by other relevant departments. Summarising the data obtained on the risks of all the critical phases, it can be concluded that risk action should take the form of regular inspections by the quality assurance staff and the study director. By adjusting the frequency of inspections, the risk of each critical phase can be made insignificant.https://www.vedomostincesmp.ru/jour/article/view/375critical phasespreclinical studyrisk managementquality management systemtesting centre
spellingShingle S. V. Khodko
M. N. Makarova
V. G. Makarov
S. S. Salynov
N. V. Rodionova
Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
Регуляторные исследования и экспертиза лекарственных средств
critical phases
preclinical study
risk management
quality management system
testing centre
title Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
title_full Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
title_fullStr Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
title_full_unstemmed Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
title_short Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis
title_sort determination of the critical phases of the experimental research using laboratory animals risk analysis
topic critical phases
preclinical study
risk management
quality management system
testing centre
url https://www.vedomostincesmp.ru/jour/article/view/375
work_keys_str_mv AT svkhodko determinationofthecriticalphasesoftheexperimentalresearchusinglaboratoryanimalsriskanalysis
AT mnmakarova determinationofthecriticalphasesoftheexperimentalresearchusinglaboratoryanimalsriskanalysis
AT vgmakarov determinationofthecriticalphasesoftheexperimentalresearchusinglaboratoryanimalsriskanalysis
AT sssalynov determinationofthecriticalphasesoftheexperimentalresearchusinglaboratoryanimalsriskanalysis
AT nvrodionova determinationofthecriticalphasesoftheexperimentalresearchusinglaboratoryanimalsriskanalysis